{"Clinical Trial ID": "NCT00617942", "Intervention": ["INTERVENTION 1:", "Cohort 1", "[Unspecified]", "INTERVENTION 2:", "Cohort 2", "[Unspecified]"], "Eligibility": ["Incorporation criteria:", "Adenocarcinoma of histologically documented breast", "ANC > 1000 cells", "Women; age > 18; Zubrod PS 0-1", "\u2014 Blisters > 100 000", "Stage IIA-IIIB disease", "Total Bilirubine < or = LSN", "No signs of metastatic disease No pregnancy or lactation", "No previous systemic treatment for breast cancer", "Serum creatinine < 1.5 mg/dl or Creat Cl > 30 ml/min", "Serum ALT < 2.5 x ULN", "The ER, PR and HER2 status is required.", "LVEF (MUGA/echo)WNL", "No beginning > 2 neuropathy", "Hemoglobin > 9.0 gm/dl", "- HER2+, defined by the ratio IHC 3+ or FISH > 2.0"], "Results": ["Performance measures:", "Number of patients with a complete pathological response rate observed after treatment with carboplatin q3weeks, weekly abraxane, and trastuzumab weekly in resectable, non-resectable LABC;", "These numbers represent patients with an RCB score of zero (0). RCB represents the residual burden of cancer.", "Time limit: 1 year", "Results 1:", "Title of the arm/group : Cohort 1", "Description of arm/group: [Unspecified]", "Total number of participants analysed: 37", "Type of measurement: Number", "Unit of measurement: participants 12", "Results 2:", "Title of the arm/group: Cohort 2", "Description of arm/group: [Unspecified]", "Total number of participants analysed: 23", "Type of measurement: Number", "Unit of measurement: participants 13"], "Adverse Events": ["Undesirable Events 1:", "Total: 7/37 (18.92 per cent)", "Infection at gr 3port, 1/37 (2.70%)", "1/37 (2.70%)", "Febrile Neutropenia 1/37 (2.70%)", "Intubated septicaemia [1]1/37 (2.70%)", "Diarrhoea gr 2, Nausea gr 3, infection gr 3 1/37 (2.70%)", "Normal ANC/viral infection grade 1 1/37 (2.70%)", "Dehydration 3, Diarrhoea 3, Vomiting 3, HGB3, Nausea 3, K 3, Dyspnoea 2 1/37 (2.70%)", "Gr 3cellulite - breast 1/37 (2.70%)", "Adverse Events 2:", "Total: 8/23 (34.78 per cent)", "Gr 3 port infection, 0/23 (0.00 %)", "- Flu 0/23 (0.00 per cent)", "Febrile Neutropenia 0/23 (0.00 %)", "Gr 4 sepsis, intube [1]0/23 (0.00 %)", "Diarrhoea gr 2, Nausea gr 3, infection gr 3 0/23 (0.00 %)", "Normal ANC/viral infection grade 1 0/23 (0.00 %)", "Dehydration 3, Diarrhoea 3, Vomiting 3, HGB3, Nausea 3, K 3, Dyspnoea 2 0/23 (0.00 %)", "Gr 3cellulite - breast 0/23 (0.00 %)"]}